Marilyn Matz

About Marilyn Matz

Paradigm4’s Agile Science™ Platform, REVEAL™, transforms hypothesis generation and validation to advance drug discovery, biomarkers, and precision medicine. Use the REVEAL suite of extensible apps to build decisive evidence from complex, heterogeneous data across proprietary and public datasets. REVEAL provides FAIR data access and elastically scalable analytics and machine learning to power discovery from population-scale to n-of-1. Leading Life Sciences, MIoT, instrument companies, and research institutes use Paradigm4’s integrative analytics platform and apps for collaborative, reproducible research. The company was founded by renowned database researcher, Turing Award laureate MIT Professor Michael Stonebraker.

Experience

1. CEO & Co-founder

   Paradigm4

   Jan 2010 — Present

   Paradigm4 is a platform-enabled biomedical analytics company catalyzing Life Sciences discovery and validation. Our REVEAL™ biomedical analytics platform provides a unified environment for scientific data management, massively scalable computing, biomedical analytics, and AI-driven research, enabling users to fully leverage complex, multimodal datasets. Our flexFS filesystem enables users to scale their science, not their spend from secondary and tertiary analytics workflows to cryoEM data storage. Paradigm4’s long-standing partnerships and customer renewals underscore the platform\'s proven scientific and business value in accelerating drug discovery and precision medicine.

Education

• Massachusetts Institute of Technology

  M.S., Computer Science

  1976 — 1981

Skills

• Automation
• Go-to-Market Strategy
• Product Development
• Software Development
• Strategic Partnerships
• Product Management
• Robotics
• Machine Vision
• Entrepreneurship
• Computer Vision
• Start-Ups
• Cloud Computing
• Business Development
• Digital Marketing
• Product Marketing
• Saas